You have 9 free searches left this month | for more free features.

City

Bethesda (1)

Utrecht (1)

Condition

Adenocarcinoma (1)

Arterial Calcification (1)

CD73 Deficiency (1)

Esophageal Cancer (1)

Fahr Disease (1)

Fahr Syndrome (1)

Primary Familial Brain Calcification (1)

Pseudoxanthoma Elasticum (1)

Squamous Cell Carcinoma (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 3 (1)

Sponsor

UMC Utrecht (2)

National Heart, Lung, and Blood Institute (NHLBI) (1)

Organon and Co (1)

Collaborator

Netherlands Brain Foundation (1)

World Health Information Science Consultants, LLC (1)

Intervention

etidronate (4)

placebo (2)

alendronate (1)

ibandronate (1)

mri scan (1)

raloxifene (1)

risedronate (1)

Study Documents

Intervention Type

drug (4)

device (1)

Funder Type

Other (2)

Industry (1)

NIH (1)

Study Type

Interventional (3)

Observational (1)

etidronate

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Fahr Disease, Fahr Syndrome, Primary Familial Brain Calcification Trial (Etidronate, Placebo)

Not yet recruiting

Fahr Disease
+2 more

Etidronate
Placebo

(no location specified)

Dec 14, 2022

Arterial Calcification, CD73 Deficiency Trial run by the NHLBI (Etidronate, MRI Scan)

Completed

Arterial Calcification
CD73 Deficiency

Etidronate
MRI Scan

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Sep 9, 2022

Pseudoxanthoma Elasticum Trial in Utrecht (Etidronate, Placebo)

Recruiting

Pseudoxanthoma Elasticum

Etidronate
Placebo

Utrecht, Netherlands

University Medical Center Utrecht

Apr 14, 2023

Rates of Esophageal Cancer in Women Taking Medications for

Completed

Esophageal Cancer
+2 more

Alendronate
+4 more

(no location specified)

Feb 1, 2022